Louisville, Colo. (January 26, 2021)—Quicksilver Scientific is partnering with Truss CBD USA—a joint venture between Molson Coors and HEXO Cannabis—to provide patent-pending nanoemulsion delivery technology for use in Veryvell, Truss’s new U.S. line of non-alcoholic, hemp-derived CBD beverages. The lineup of ready-to-drink hemp-derived CBD products includes three different blends of CBD and adaptogens that offer different wellness combinations, delivered via Quicksilver Scientific’s innovative nanoemulsion delivery technology. Veryvell is now available in Colorado, a state known for being an early cannabis adopter with a regulatory infrastructure for consumable CBD products already in place.
The U.S. launch of the Veryvell line represents an ambitious leap into a new, non-alcoholic market for Molson Coors and builds upon a successful two-year partnership between Quicksilver and Truss Beverages in Canada. There, the two companies collaborated on development and production of Veryvell’s line of water-soluble cannabis products, which also rely on Quicksilver’s sophisticated delivery technologies to ensure an efficacious and consistent effect. “Quicksilver has proven themselves to be exceptional in terms of quality, efficacy and consistency. As a result, we naturally wanted to extend that partnership to our new U.S. venture, ensuring that these products also provide a best-in-class consumer experience,” said Jane Armstrong Hockman, General Manager, Truss CBD USA.
Quicksilver Scientific applied its extensive experience developing nutraceutical protocols to contribute to Veryvell’s three unique formulations, each intended to deliver an entourage of distinctive benefits. The three blends include “Focus” (grapefruit and tarragon with ginseng and guarana), “Mind & Body” (strawberry and hibiscus with ashwagandha and elderberry) and “Unwind” (blueberry and lavender flavors with ashwagandha and L-Theanine).
Over the past decade, Quicksilver Scientific has perfected the nanoemulsion technology that powers Veryvell hemp-derived CBD beverages. The droplets sheathing the minuscule CBD particles are so small they pass right between cells and enter the bloodstream directly, meaning faster absorption and higher bioavailability in the body. “CBD is not water-soluble, which creates challenges for manufacturers when attempting to mix it into beverages. Our innovative nanoemulsion technology overcomes these challenges by encapsulating nano-sized CBD particles in water-soluble spheres that can be directly added to beverages. The result is a clear, great-tasting product with greater bioavailability, a measure of a compound’s concentration that is absorbed into the body’s bloodstream,” said Dr. Christopher Shade, Ph.D., Founder & CEO of Quicksilver Scientific. Their microscopic size also provides greater transparency in appearance, which is key to beverage applications and stands in direct contrast to the hazy or cloudy appearance of competing emulsions currently being used in the cannabis beverage market.
“The marketplace is saturated with a fairly homogeneous product offering. The Veryvell range, resulting from a highly productive and stimulating collaboration between Quicksilver Scientific and Truss Beverage, is a testament to the real potential for experiential and quality innovation within the non-alcoholic beverage industry,” said Jason Dyer, President, Quicksilver Scientific. “Innovation is what we do at Quicksilver Scientific, and we look forward to expanding our capabilities through future opportunities and challenges with partners like Truss. In doing so, we expect to disrupt and drive the category with products that deliver a more effective, consistent and predictable experience for consumers.”
Quicksilver Scientific’s role in the partnership benefits from the recent addition of David Durkee, Ph.D., as Vice President of New Ventures at Quicksilver. Durkee came to Quicksilver from Molson Coors, where he spent nearly a decade in a wide range of roles, including global product development.
“Combining Quicksilver’s technology and deep knowledge of nutraceuticals with Truss CBD USA’s expertise in manufacturing, logistics and marketing will allow us to elevate Veryvell hemp-derived CBD beverages, demonstrating what the hemp-derived CBD beverage market is capable of,” Durkee said.
For more information or to schedule an interview with Quicksilver Scientific, please contact Shawna Seldon McGregor at 917-971-7852 or [email protected].
Quicksilver Scientific®: Powering Natural Health
Quicksilver Scientific, Inc. is a leading manufacturer of nutritional supplements featuring proprietary enhanced delivery systems. The company’s advanced liposomal supplements are highly bioavailable and support vital health functions from absorption of essential vitamins to the elimination of ubiquitous toxins, enabling consumers to achieve their genetic potential. Located in Louisville, Colo.,Quicksilver Scientific, Inc. is #652 on the 2019 Inc. 5000, ranking #3 among Boulder metro companies. For more information, visitwww.quicksilverscientific.com. Shop our products. Learn more about our science on YouTube. Continue the conversation on Facebook,Instagram, Twitter, LinkedIn and Pinterest.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
There’s a growing industry here in North Carolina, and with it come countless rules, gray areas, and legal confusion—and no, we’re not talking about NFTs. The hemp industry has been blooming in the state for years, but North Carolina is one of 12 states that doesn’t have a medical marijuana program. With the end of the…
New York’s recreational marijuana market is beginning to sprout, literally, with thin-leafed plants stretching toward the sun in farms around the state. In a novel move, New York gave 203 hemp growers first shot at cultivating marijuana destined for legal sales, which could start by the end of the year. Big indoor growers are expected to join…
Legislation that would protect Pennsylvania’s more than 700,000 medical marijuana patients from wrongful driving under the influence convictions advanced out of the Senate Transportation Committee on Tuesday by a 13-0 vote. The bill would treat medical cannabis like any other prescription narcotic. It would require proof of impairment that interferes with a person’s ability to…
D.C. residents who are 21 and older will soon be able to self-certify their eligibility for medical marijuana under a proposal passed by the D.C. Council on Tuesday, which also approved measures allowing some minors to get certain vaccines without their parents’ consent and another bill to give residents at risk of foreclosure more time…